drugset / Trial / NCT02909569
Relieving Chronic Itch: Oral Medication
NaSingle-groupOpen-labelTreatment
Summary
This study evaluates the effect of twice daily dose of INCB39110 in the treatment of itch in adults.
Timeline
- Start
- 2018-08
- Primary completion
- 2018-10-09
- Completion
- 2018-10-09
Outcome
Outcome not reported
Stopped: “Contract could not be agreed on.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itacitinib | Small molecule | 400 mg | Oral |
Indications
No indication recorded.